Cocrystal Pharma, Inc. - Common Stock, par value $0.001 per share (COCP)

15 filings reported holding COCP - Cocrystal Pharma, Inc. - Common Stock, par value $0.001 per share as of Q1 2024.
Cocrystal Pharma, Inc. - Common Stock, par value $0.001 per share (COCP) has 14 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 721,322 shares of 13,831,528 outstanding shares and own 5.2% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (275,656 shares), RENAISSANCE TECHNOLOGIES LLC (126,028 shares), BlackRock Inc. (73,746 shares), GEODE CAPITAL MANAGEMENT, LLC (60,432 shares), MORGAN STANLEY (59,271 shares), SUSQUEHANNA INTERNATIONAL GROUP, LLP (52,130 shares), STATE STREET CORP (24,443 shares), UBS Group AG (20,258 shares), NORTHERN TRUST CORP (12,207 shares), and BANK OF AMERICA CORP /DE/ (8,975 shares).
This table shows the top 14 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.